The role of the biopsy of the transitonal zone and of the seminal vesicles in the diagnosis and staging of prostate cancer

European Urology, Supplement

Volumn 1, Issue 6, 2002, Pages 40-46

  Peyromaure, Michaël ^a   Ravery, Vincent ^a   Boccon Gibod, Laurent ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Biopsy; Prostatic neoplasms; Seminal vesicles; Transition zone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SEMINAL VESICLE; TUMOR BIOPSY;

EID: 0036765794     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9056(02)00056-8     Document Type: Article

References (52)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-5.
2. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995;45:2-12.
3. Guillonneau B, Vallancien G. What is the prognostic significance of seminal vesicle invasion by prostate cancer? Prostate 1998;36:207-8.
4. McNeal JE. The zonal anatomy of the prostate. Prostate 1981;2:35-49.
5. Epstein JI, Walsh PC, Carmichael M, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. JAMA 1994;271:368-74.
6. Carter HB, Sauvageot J, Walsh PC. Prospective evaluation of men with stage Tic adenocarcinoma of the prostate. J Urol 1997;157: 2206-9.
7. Stamey TA, Sözen TS, Yemoto CM, et al. Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: common ground for therapeutic trials and TNM subgroups. J Urol 1998;159:2009-12.
8. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-903.
9. Shiraishi T, Ioshii SO, Watanabe M, Kato H, Imai H, Kawai K, Yatani R. Geographic pathology of latent prostatic carcinoma: an international comparison. Fundamental approaches to the diagnosis and treatment for prostate cancer and BPH. Albany: Adenine Press, 1994. p. 21-5.
10. Greene DR, Wheeler TM, Egawa S. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 1991;146:1069-76.
11. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000;89:1800-9.
12. Grignon DJ, Sakr WA. Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? J Cell Biochem Suppl 1994;19:267-9.
13. Noguchi M, Stamey TA, McNeal JE, Yemoto CEM. An analysis of 148 consecutive transition zone cancers: clinical and pathological characteristics. J Urol 2000;163:1751-5.
14. Sakr WA, Grignon DJ. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Anal Quant Cytol Histol 1998;20:417-23.
15. Wheeler TM. Anatomic considerations in carcinoma of the prostate. Urol Clin North Am 1989;16:623-4.
16. McNeal JE. Cancer volume and site of origin of adenocarcinoma of the prostate: relationship to local and distant spread. Hum Pathol 1992;23:258-66.
17. Lui PD, Terris MK, McNeal JE, Stamey TA. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 1995;153:1000-3.
18. Stamey TA, Yemoto CE. The clinical importance of separating transition zone (TZ) from peripheral zone (PZ) cancers. J Urol Suppl 1998;159:221 [abstract].
19. Eskew LA, Bare RL, McCullough DL. Systematic five-region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1996;157:199-202.
20. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod LA. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000;164:393-6.
21. Epstein JI, Walsh PC, Carter HB. Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology 2001; 57:1112-6.
22. Gore JL, Shariat SF, Miles BJ, Kadmon D, Jiang N, Wheeler TM, et al. Optimal combinations of systemic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 2001; 165:1554-9.
23. Bazinet M, Karakiewicz PI, Aprikan AG, Trudel C, Aronson S, Nachabe M, et al. Value of systematic transition zone biopsies in early detection of prostate cancer. J Urol 1996;155:605-6.
24. Terris MK, Pham TQ, Issa MM, Kabalin JN. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 1997;157:204-6.
25. Onder AU, Yalcin V, Arar O, Yaycioglu O, Citi A, Solock V. Impact of transition zone biopsies in detection and evaluation of prostate cancer. Eur Urol 1998;33:542-8.
26. Morote J, Lopez M, Encabo G, de Torres I. Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time. Eur Urol 1999;35:294-7.
27. Kojima Y. Nonomura N, Nose T, Inoue T. Tsuda K. Narumi, Nar-umi Y, et al. Transition zone biopsy in the detection of prostate cancer. Eur Urol 2000;37:675-9.
28. Fleshner EN, Fair WR. Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 1997;157:556-8.
29. Chang JJ, Shinohara K, Hovey RM, Montgomery C, Presti Jr JC. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection. Urology 1998;52:89-93.
30. Presti Jr JC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy schema should include eight rather than six biopsies. Results of a prospective clinical trial. J Urol 2000;163: 163-7.
31. Liu IJ, Macy M, Lai Y-H, Terris MK. Critical evaluation of the current indications for transition zone biopsies. Urology 2001;57: 1117-20.
32. Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostatic specific antigen values. J Urol 1995:154:1795-7.
33. Manseck A, Guhr K, Froehner M, Hakenberg OW, Wirth MP. Morbidity and discomfort of 10-core biopsy of the prostate evaluated by questionnaire. Urol Int 2001;66:197-200.
34. Mukamel E, De Kernion JB, Hannah J, Smith RB, Skinner DG, Goodwin WE. The incidence and significance of vesicle invasion in patients with adenocarcinoma of the prostate. Cancer 1987;59: 1535-8.
35. Walsh PC, Partin AW, Epstein FI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831-6.
36. Potter SR, Mangold LA, Shue MJ, Taylor DC, Lecksell KL, Epstein JI. et al. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy. Cancer 2000;89:2577-86.
37. Vallancien G, Prapotnich D, Veillon B, Brisset JM, André-Bougaran J. Seminal vesicle biopsies in the preoperative staging of prostatic cancer. Eur Urol 1991;19:196-200.
38. Partin AW, Yoo J, Carter HB. Pearson JD, Chan DW, Epstein JI, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathologic stage in men with localized prostate cancer. J Urol 1993;150:110-4.
39. Terris MK, McNeal JE, Freiha FS, Stamey TA. Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J Urol 1993;149: 1035-9.
40. Allepuz Losa CA, Sanz Velez JI, Gil Sanz MJ, Plaza Mas L, Rioja Sanz LA. Seminal vesicle biopsy in prostate cancer staging. J Urol 1995;154:1407-11.
41. Stone NN, Stock RG, Unger P. Indications for seminal biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol 1995;154:1392-6.
42. Guillonneau B. Debras B, Veillon B, Bougaran J, Chambon E, Vallancien G. Indications for preoperative seminal vesicle biopsies in staging of clinically localized prostatic cancer. Eur Urol 1997;32:160-5.
43. Peller PA, Young DC, Marmaduke DP, Marsh WL. Badalament RA. Sextant prostate biopsies: a histopathologic correlation with radical prostatectomy specimens. Cancer 1995;75:530-8.
44. Wills ML, Sauvageot J, Partin AW, Gurganus R, Epstein JI. Ability of sextant biopsies to predict radical prostatectomy stage. Urology 1998;51:759-64.
45. Egawa S, Suyama K, Matsumoto K, Satoh T, Uchida T, Kuwao S, et al. Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 1998;52:433-40.
46. Ravery V, Schmid HP, Toublanc M, Boccon-Gibod LA. Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate cancer? Cancer 1996;78:1079-84.
47. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Meulmans A, Toublanc M, et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/ recurrent detectable PSA after radical prostatectomy. Urology 1994;44:371-6.
48. Ravery V, Limot O, Tobolski F, Boccon-Gibod LA, Toublanc M, Hermieu JF, et al. Advances in the assessment of clinically localized prostate cancer. Eur Urol 1996;29:257-65.
49. Debras B, Guillonneau B, Bougaran J, Chambon E, Vallancien G. Prognostic significance of seminal vesicle invasion on the radical prostatectomy specimen. Eur Urol 1998;33:271-7.
50. Vallancien G, Bochereau G, Wetzel O, Bretheau D, Prapotnich D, Bougaran J. Influence of preoperative positive seminal vesicle biopsy on the staging of prostate cancer. J Urol 1994;52:1152-6.
51. May F, Treumann T, Dettmar P, Hartung R, Breul J. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 2001;87:66-9.
52. Ogura K, Maekawa S, Okubo K, Aoki Y, Okada T, Oda K, et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 2001;57:721-6.